BioCryst Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US09058V1035

SecurityBCRX / BioCryst Pharmaceuticals, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Ownership 3.80%
Citadel Advisors Llc ownership in BCRX / BioCryst Pharmaceuticals, Inc.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (BCRX) in the form of stock options. The firm currently holds call options representing 56,885 of underlying shares valued at $541,545 USD and put options representing 139,318 of underlying shares valued at $1,326,307 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2021-02-16 2021-02-16 13G/A 3.80 -24.00
2020-06-10 2020-06-10 13G 5.00

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

BCRX / BioCryst Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 1,018,743 -280,159 -21.57 9,698 -4.27 0.0014
2026-02-17 2025-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 1,298,902 -60,980 -4.48 10,131 -1.84 0.0015
2025-11-14 2025-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 1,359,882 -1,197,550 -46.83 10,322 -54.96 0.0016
2025-08-14 2025-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 2,557,432 1,983,243 345.40 22,915 432.14 0.0040
2025-05-15 2025-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 574,189 315,644 122.08 4,306 121.50 0.0008
2025-02-14 2024-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 258,545 -20,598 -7.38 1,944 -8.35 0.0003
2024-11-14 2024-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 279,143 -38,836 -12.21 2,121 7.94 0.0004
2024-08-14 2024-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 317,979 157,894 98.63 1,965 141.70 0.0004
2024-05-15 2024-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 160,085 -209,551 -56.69 813 -63.28 0.0002
2024-02-14 2023-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 369,636 -1,011,234 -73.23 2,214 -77.35 0.0004
2023-11-14 2023-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 1,380,870 321,309 30.32 9,777 31.06 0.0021
2023-08-14 2023-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 1,059,561 154,491 17.07 7,459 -1.18 0.0015
2023-05-15 2023-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 905,070 846,651 1,449.27 7,548 1,026.57 0.0017
2023-02-14 2022-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 58,419 -912,896 -93.99 671 -94.53 0.0002
2022-11-14 2022-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 971,315 428,854 79.06 12,239 113.26 0.0028
2022-08-15 2022-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 542,461 93,305 20.77 5,739 -21.42 0.0015
2022-05-16 2022-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 449,156 50,783 12.75 7,303 32.35 0.0015
2022-02-14 2021-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 398,373 -557,481 -58.32 5,518 -59.83 0.0011
2021-11-15 2021-09-30 13F BIOCRYST PHARMACEUTICALS Cmn 09058V103 955,854 -77,449 -7.50 13,736 -15.92 0.0029
2021-08-16 2021-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 1,033,303 225,691 27.95 16,337 98.92 0.0037
2021-05-21 2021-03-31 13F/A-1 BIOCRYST PHARMACEUTICALS COM 09058V103 807,612 -5,688,305 -87.57 8,213 -83.03 0.0020
2021-05-17 2021-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 807,612 -5,688,305 8,213 0.0020
2021-02-16 2020-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 6,495,917 -2,168,814 -25.03 48,394 62.60 0.0126
2020-11-16 2020-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 8,664,731 179,023 2.11 29,763 -26.39 0.0084
2020-08-14 2020-06-30 13F BIOCRYST PHARMACEUTICALS Cmn 09058V103 8,485,708 2,376,174 38.89 40,434 230.91 0.0144
2020-05-15 2020-03-31 13F BIOCRYST PHARMACEUTICALS Cmn 09058V103 6,109,534 153,555 2.58 12,219 -40.53 0.0055
2020-02-14 2019-12-31 13F BIOCRYST PHARMACEUTICALS Cmn 09058V103 5,955,979 2,122,508 55.37 20,548 87.09 0.0089
2019-11-14 2019-09-30 13F BIOCRYST PHARMACEUTICALS Cmn 09058V103 3,833,471 340,873 9.76 10,983 -17.03 0.0052
2019-08-14 2019-06-30 13F BIOCRYST PHARMACEUTICALS Cmn 09058V103 3,492,598 1,283,723 58.12 13,237 -26.38 0.0061
2019-05-15 2019-03-31 13F BIOCRYST PHARMACEUTICALS Cmn 09058V103 2,208,875 1,488,671 206.70 17,980 209.36 0.0089
2019-02-14 2018-12-31 13F BIOCRYST PHARMACEUTICALS Cmn 09058V103 720,204 665,917 1,226.66 5,812 1,300.48 0.0032
2018-11-13 2018-09-30 13F BIOCRYST PHARMACEUTICALS Cmn 09058V103 54,287 -12,402 -18.60 415 8.64 0.0002
2018-08-14 2018-06-30 13F/A-1 BIOCRYST PHARMACEUTICALS Cmn 09058V103 66,689 -395,390 -85.57 382 -82.67 0.0002
2018-08-10 2018-06-30 13F BIOCRYST PHARMACEUTICALS Cmn 09058V103 66,689 -395,390 382
2018-05-14 2018-03-31 13F/A-1 BIOCRYST PHARMACEUTICALS Cmn 09058V103 462,079 462,079 2,204 0.0012
2018-05-11 2018-03-31 13F BIOCRYST PHARMACEUTICALS Cmn 09058V103 462,079 462,079 2,204
2018-02-09 2017-12-31 13F BIOCRYST PHARMACEUTICALS Cmn 09058V103 0 -1,395,547 -100.00 0 -100.00
2017-11-09 2017-09-30 13F BIOCRYST PHARMACEUTICALS Cmn 09058V103 1,395,547 1,239,689 795.40 7,313 744.46 0.0056
2017-08-11 2017-06-30 13F BIOCRYST PHARMACEUTICALS Cmn 09058V103 155,858 21,333 15.86 866 -23.36 0.0007
2017-05-12 2017-03-31 13F BIOCRYST PHARMACEUTICALS Cmn 09058V103 134,525 23,671 21.35 1,130 60.97 0.0010
2017-02-10 2016-12-31 13F BIOCRYST PHARMACEUTICALS Cmn 09058V103 110,854 110,854 702 0.0007
2017-01-31 2015-12-31 13F/A-1 BIOCRYST PHARMACEUTICALS INC CMN STK Cmn 09058V103 0 -143,954 -100.00 0 -100.00
2015-11-16 2015-09-30 13F BIOCRYST PHARMACEUTICALS INC CMN STK Cmn 09058V103 143,954 -650,637 -81.88 1,641 -86.17 0.0016
2015-08-14 2015-06-30 13F BIOCRYST PHARMACEUTICALS INC CMN STK Cmn 09058V103 794,591 757,207 2,025.48 11,863 3,409.76 0.0104
2015-05-15 2015-03-31 13F BIOCRYST PHARMACEUTICALS INC CMN STK Cmn 09058V103 37,384 37,384 0.00 338 0.0004
2015-02-17 2014-12-31 13F BIOCRYST PHARMACEUTICALS INC CMN STK Cmn 09058V103 0 -93,409 -100.00 0 -100.00
2014-11-14 2014-09-30 13F BIOCRYST PHARMACEUTICALS INC CMN STK Cmn 09058V103 93,409 -2,659 -2.77 914 -25.33 0.0011
2014-08-14 2014-06-30 13F BIOCRYST PHARMACEUTICALS INC CMN STK Cmn 09058V103 96,068 85,247 787.79 1,224 973.68 0.0017
2014-05-15 2014-03-31 13F BIOCRYST PHARMACEUTICALS INC CMN STK Cmn 09058V103 10,821 -31,982 -74.72 114 -64.92 0.0002
2014-02-14 2013-12-31 13F BIOCRYST PHARMACEUTICALS INC CMN STK Cmn 09058V103 42,803 12,829 42.80 325 606.52 0.0004
2013-08-14 2013-06-30 13F BIOCRYST PHARMACEUTICALS INC CMN STK Cmn 09058V103 29,974 29,974 46 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F BIOCRYST PHARMACEUTICALS COM Call 56,885 -30.29 542 -14.94 n/a n/a n/a
2026-02-17 2025-12-31 13F BIOCRYST PHARMACEUTICALS COM Call 81,600 182.35 636 190.41 n/a n/a n/a
2025-11-14 2025-09-30 13F BIOCRYST PHARMACEUTICALS COM Call 28,900 -35.63 219 -45.52 n/a n/a n/a
2025-08-14 2025-06-30 13F BIOCRYST PHARMACEUTICALS COM Call 44,900 -11.96 402 5.24 n/a n/a n/a
2025-05-15 2025-03-31 13F BIOCRYST PHARMACEUTICALS COM Call 51,000 -59.27 382 -59.40 n/a n/a n/a
2025-02-14 2024-12-31 13F BIOCRYST PHARMACEUTICALS COM Call 125,200 -10.44 942 -11.39 n/a n/a n/a
2024-11-14 2024-09-30 13F BIOCRYST PHARMACEUTICALS COM Call 139,800 46.54 1,062 80.31 n/a n/a n/a
2024-08-14 2024-06-30 13F BIOCRYST PHARMACEUTICALS COM Call 95,400 73.45 590 111.11 n/a n/a n/a
2024-05-15 2024-03-31 13F BIOCRYST PHARMACEUTICALS COM Call 55,000 -88.26 279 -90.05 n/a n/a n/a
2024-02-14 2023-12-31 13F BIOCRYST PHARMACEUTICALS COM Call 468,300 -14.43 2,805 -27.59 n/a n/a n/a
2023-11-14 2023-09-30 13F BIOCRYST PHARMACEUTICALS COM Call 547,300 -9.25 3,875 -8.74 n/a n/a n/a
2023-08-14 2023-06-30 13F BIOCRYST PHARMACEUTICALS COM Call 603,100 2.38 4,246 -13.60 n/a n/a n/a
2023-05-15 2023-03-31 13F BIOCRYST PHARMACEUTICALS COM Call 589,100 -11.96 4,913 -36.04 n/a n/a n/a
2023-02-14 2022-12-31 13F BIOCRYST PHARMACEUTICALS COM Call 669,100 14.40 7,681 4.22 n/a n/a n/a
2022-11-14 2022-09-30 13F BIOCRYST PHARMACEUTICALS COM Call 584,900 56.01 7,370 85.83 n/a n/a n/a
2022-08-15 2022-06-30 13F BIOCRYST PHARMACEUTICALS COM Call 374,900 -28.00 3,966 -53.16 n/a n/a n/a
2022-05-16 2022-03-31 13F BIOCRYST PHARMACEUTICALS COM Call 520,700 -36.49 8,467 -25.44 n/a n/a n/a
2022-02-14 2021-12-31 13F BIOCRYST PHARMACEUTICALS COM Call 819,900 7.08 11,356 3.21 n/a n/a n/a
2021-11-15 2021-09-30 13F BIOCRYST PHARMACEUTICALS Cmn Call 765,700 27.53 11,003 15.92 n/a n/a n/a
2021-08-16 2021-06-30 13F BIOCRYST PHARMACEUTICALS COM Call 600,400 22.83 9,492 90.95 n/a n/a n/a
2021-05-21 2021-03-31 13F/A BIOCRYST PHARMACEUTICALS COM Call 488,800 196.60 4,971 304.80 n/a n/a n/a
2021-05-17 2021-03-31 13F BIOCRYST PHARMACEUTICALS COM Call 488,800 4,971 n/a n/a n/a
2021-02-16 2020-12-31 13F BIOCRYST PHARMACEUTICALS COM Call 164,800 -3.00 1,228 110.27 n/a n/a n/a
2020-11-16 2020-09-30 13F BIOCRYST PHARMACEUTICALS COM Call 169,900 -25.02 584 -45.93 n/a n/a n/a
2020-08-14 2020-06-30 13F BIOCRYST PHARMACEUTICALS Cmn Call 226,600 580.48 1,080 1,511.94 n/a n/a n/a
2020-05-15 2020-03-31 13F BIOCRYST PHARMACEUTICALS Cmn Call 33,300 67 n/a n/a n/a
2020-02-14 2019-12-31 13F BIOCRYST PHARMACEUTICALS Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-11-14 2019-09-30 13F BIOCRYST PHARMACEUTICALS Cmn Call 11,700 -68.12 34 -75.54 n/a n/a n/a
2019-08-14 2019-06-30 13F BIOCRYST PHARMACEUTICALS Cmn Call 36,700 76.44 139 -17.75 n/a n/a n/a
2019-05-15 2019-03-31 13F BIOCRYST PHARMACEUTICALS Cmn Call 20,800 169 n/a n/a n/a
2018-05-14 2018-03-31 13F/A BIOCRYST PHARMACEUTICALS Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-09 2017-12-31 13F BIOCRYST PHARMACEUTICALS Cmn Call 22,500 63.04 110 52.78 n/a n/a n/a
2017-11-09 2017-09-30 13F BIOCRYST PHARMACEUTICALS Cmn Call 13,800 -38.94 72 -42.86 n/a n/a n/a
2017-08-11 2017-06-30 13F BIOCRYST PHARMACEUTICALS Cmn Call 22,600 -53.21 126 -68.97 n/a n/a n/a
2017-05-12 2017-03-31 13F BIOCRYST PHARMACEUTICALS Cmn Call 48,300 58.88 406 111.46 n/a n/a n/a
2017-02-10 2016-12-31 13F BIOCRYST PHARMACEUTICALS Cmn Call 30,400 2.36 192 46.56 n/a n/a n/a
2017-01-31 2016-09-30 13F/A BIOCRYST PHARMACEUTICALS Cmn Call 29,700 91.61 131 197.73 n/a n/a n/a
2016-11-10 2016-09-30 13F BIOCRYST PHARMACEUTICALS INC CMN STK Cmn Call 29,700 131 n/a n/a n/a
2017-01-31 2016-06-30 13F/A BIOCRYST PHARMACEUTICALS Cmn Call 15,500 -21.32 44 -21.43 n/a n/a n/a
2016-08-12 2016-06-30 13F BIOCRYST PHARMACEUTICALS INC CMN STK Cmn Call 15,500 44 n/a n/a n/a
2017-01-31 2016-03-31 13F/A BIOCRYST PHARMACEUTICALS Cmn Call 19,700 28.76 56 -64.56 n/a n/a n/a
2016-05-13 2016-03-31 13F BIOCRYST PHARMACEUTICALS INC CMN STK Cmn Call 19,700 56 n/a n/a n/a
2017-01-31 2015-12-31 13F/A BIOCRYST PHARMACEUTICALS Cmn Call 15,300 -98.12 158 -98.30 n/a n/a n/a
2016-02-12 2015-12-31 13F BIOCRYST PHARMACEUTICALS Cmn Call 15,300 158 n/a n/a n/a
2015-11-16 2015-09-30 13F BIOCRYST PHARMACEUTICALS INC CMN STK Cmn Call 813,800 2,848.55 9,277 2,151.70 n/a n/a n/a
2015-08-14 2015-06-30 13F BIOCRYST PHARMACEUTICALS INC CMN STK Cmn Call 27,600 181.63 412 368.18 n/a n/a n/a
2015-05-15 2015-03-31 13F BIOCRYST PHARMACEUTICALS INC CMN STK Cmn Call 9,800 -64.62 88 -73.89 n/a n/a n/a
2015-02-17 2014-12-31 13F BIOCRYST PHARMACEUTICALS Cmn Call 27,700 -14.51 337 6.31 n/a n/a n/a
2014-11-14 2014-09-30 13F BIOCRYST PHARMACEUTICALS INC CMN STK Cmn Call 32,400 -55.37 317 -65.77 n/a n/a n/a
2014-08-14 2014-06-30 13F BIOCRYST PHARMACEUTICALS INC CMN STK Cmn Call 72,600 0.00 926 20.57 n/a n/a n/a
2014-05-15 2014-03-31 13F BIOCRYST PHARMACEUTICALS Cmn Call 72,600 50.00 768 108.70 n/a n/a n/a
2014-02-14 2013-12-31 13F BIOCRYST PHARMACEUTICALS INC CMN STK Cmn Call 48,400 -9.19 368 -5.15 n/a n/a n/a
2013-11-14 2013-09-30 13F BIOCRYST PHARMACEUTICALS Cmn Call 53,300 542.17 388 2,884.62 n/a n/a n/a
2013-08-14 2013-06-30 13F BIOCRYST PHARMACEUTICALS INC CMN STK Cmn Call 8,300 13 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F BIOCRYST PHARMACEUTICALS COM Put 139,318 5.78 1,326 29.11 n/a n/a n/a
2026-02-17 2025-12-31 13F BIOCRYST PHARMACEUTICALS COM Put 131,700 13.83 1,027 16.97 n/a n/a n/a
2025-11-14 2025-09-30 13F BIOCRYST PHARMACEUTICALS COM Put 115,700 -0.52 878 -15.74 n/a n/a n/a
2025-08-14 2025-06-30 13F BIOCRYST PHARMACEUTICALS COM Put 116,300 22.94 1,042 46.97 n/a n/a n/a
2025-05-15 2025-03-31 13F BIOCRYST PHARMACEUTICALS COM Put 94,600 -38.97 710 -39.14 n/a n/a n/a
2025-02-14 2024-12-31 13F BIOCRYST PHARMACEUTICALS COM Put 155,000 9.46 1,166 8.27 n/a n/a n/a
2024-11-14 2024-09-30 13F BIOCRYST PHARMACEUTICALS COM Put 141,600 -33.24 1,076 -17.86 n/a n/a n/a
2024-08-14 2024-06-30 13F BIOCRYST PHARMACEUTICALS COM Put 212,100 -6.11 1,311 14.21 n/a n/a n/a
2024-05-15 2024-03-31 13F BIOCRYST PHARMACEUTICALS COM Put 225,900 9.34 1,148 -7.28 n/a n/a n/a
2024-02-14 2023-12-31 13F BIOCRYST PHARMACEUTICALS COM Put 206,600 149.52 1,238 111.09 n/a n/a n/a
2023-11-14 2023-09-30 13F BIOCRYST PHARMACEUTICALS COM Put 82,800 32.91 586 33.79 n/a n/a n/a
2023-08-14 2023-06-30 13F BIOCRYST PHARMACEUTICALS COM Put 62,300 -32.58 439 -43.12 n/a n/a n/a
2023-05-15 2023-03-31 13F BIOCRYST PHARMACEUTICALS COM Put 92,400 -57.81 771 -69.37 n/a n/a n/a
2023-02-14 2022-12-31 13F BIOCRYST PHARMACEUTICALS COM Put 219,000 -8.67 2,514 -16.78 n/a n/a n/a
2022-11-14 2022-09-30 13F BIOCRYST PHARMACEUTICALS COM Put 239,800 -19.61 3,021 -4.28 n/a n/a n/a
2022-08-15 2022-06-30 13F BIOCRYST PHARMACEUTICALS COM Put 298,300 -18.85 3,156 -47.20 n/a n/a n/a
2022-05-16 2022-03-31 13F BIOCRYST PHARMACEUTICALS COM Put 367,600 -12.93 5,977 2.22 n/a n/a n/a
2022-02-14 2021-12-31 13F BIOCRYST PHARMACEUTICALS COM Put 422,200 -50.07 5,847 -51.88 n/a n/a n/a
2021-11-15 2021-09-30 13F BIOCRYST PHARMACEUTICALS Cmn Put 845,500 47.81 12,150 34.36 n/a n/a n/a
2021-08-16 2021-06-30 13F BIOCRYST PHARMACEUTICALS COM Put 572,000 -8.19 9,043 42.72 n/a n/a n/a
2021-05-21 2021-03-31 13F/A BIOCRYST PHARMACEUTICALS COM Put 623,000 53.60 6,336 109.66 n/a n/a n/a
2021-05-17 2021-03-31 13F BIOCRYST PHARMACEUTICALS COM Put 623,000 6,336 n/a n/a n/a
2021-02-16 2020-12-31 13F BIOCRYST PHARMACEUTICALS COM Put 405,600 52.42 3,022 230.63 n/a n/a n/a
2020-11-16 2020-09-30 13F BIOCRYST PHARMACEUTICALS COM Put 266,100 20.68 914 -13.04 n/a n/a n/a
2020-08-14 2020-06-30 13F BIOCRYST PHARMACEUTICALS Cmn Put 220,500 166.95 1,051 536.97 n/a n/a n/a
2020-05-15 2020-03-31 13F BIOCRYST PHARMACEUTICALS Cmn Put 82,600 245.61 165 101.22 n/a n/a n/a
2020-02-14 2019-12-31 13F BIOCRYST PHARMACEUTICALS Cmn Put 23,900 -67.08 82 -70.18 n/a n/a n/a
2019-08-14 2019-06-30 13F BIOCRYST PHARMACEUTICALS Cmn Put 72,600 554.05 275 205.56 n/a n/a n/a
2019-05-15 2019-03-31 13F BIOCRYST PHARMACEUTICALS Cmn Put 11,100 90 n/a n/a n/a
2018-05-14 2018-03-31 13F/A BIOCRYST PHARMACEUTICALS Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-09 2017-12-31 13F BIOCRYST PHARMACEUTICALS Cmn Put 12,100 -68.32 59 -70.50 n/a n/a n/a
2017-11-09 2017-09-30 13F BIOCRYST PHARMACEUTICALS Cmn Put 38,200 200 n/a n/a n/a
2017-05-12 2017-03-31 13F BIOCRYST PHARMACEUTICALS Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-10 2016-12-31 13F BIOCRYST PHARMACEUTICALS Cmn Put 13,000 -46.72 82 -24.07 n/a n/a n/a
2017-01-31 2016-09-30 13F/A BIOCRYST PHARMACEUTICALS Cmn Put 24,400 108 n/a n/a n/a
2016-11-10 2016-09-30 13F BIOCRYST PHARMACEUTICALS INC CMN STK Cmn Put 24,400 108 n/a n/a n/a
2016-05-13 2016-03-31 13F BIOCRYST PHARMACEUTICALS Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-01-31 2015-12-31 13F/A BIOCRYST PHARMACEUTICALS Cmn Put 13,400 -33.66 138 -40.00 n/a n/a n/a
2016-02-12 2015-12-31 13F BIOCRYST PHARMACEUTICALS Cmn Put 13,400 138 n/a n/a n/a
2015-11-16 2015-09-30 13F BIOCRYST PHARMACEUTICALS INC CMN STK Cmn Put 20,200 197.06 230 125.49 n/a n/a n/a
2015-08-14 2015-06-30 13F BIOCRYST PHARMACEUTICALS INC CMN STK Cmn Put 6,800 51.11 102 148.78 n/a n/a n/a
2015-05-15 2015-03-31 13F BIOCRYST PHARMACEUTICALS INC CMN STK Cmn Put 4,500 -69.18 41 -76.97 n/a n/a n/a
2015-02-17 2014-12-31 13F BIOCRYST PHARMACEUTICALS Cmn Put 14,600 -18.89 178 1.14 n/a n/a n/a
2014-11-14 2014-09-30 13F BIOCRYST PHARMACEUTICALS INC CMN STK Cmn Put 18,000 -32.58 176 -48.24 n/a n/a n/a
2014-08-14 2014-06-30 13F BIOCRYST PHARMACEUTICALS INC CMN STK Cmn Put 26,700 -29.37 340 -15.00 n/a n/a n/a
2014-05-15 2014-03-31 13F BIOCRYST PHARMACEUTICALS Cmn Put 37,800 123.67 400 212.50 n/a n/a n/a
2014-02-14 2013-12-31 13F BIOCRYST PHARMACEUTICALS INC CMN STK Cmn Put 16,900 119.48 128 128.57 n/a n/a n/a
2013-11-14 2013-09-30 13F BIOCRYST PHARMACEUTICALS Cmn Put 7,700 862.50 56 5,500.00 n/a n/a n/a
2013-08-14 2013-06-30 13F BIOCRYST PHARMACEUTICALS INC CMN STK Cmn Put 800 1 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.